Back to Authors

McCormick, Benjamin J

0000-0003-3678-5615

Mayo Clinic

Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.

Citations 4

Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemia

Leukemia & Lymphoma | October 10, 2025 | Volume: 66 | Issue: 14 | Pages: 2717-2727

10.1080/10428194.2025.2564766 | PMID 41070588

Corticosteroid-induced hyperammonaemic encephalopathy in a woman with late-onset ornithine transcarbamylase deficiency

BMJ Case Reports | May 2, 2024 | Volume: 17 | Issue: 5 | Pages: e255793

10.1136/bcr-2023-255793 | PMID 38697679

Ornithine transcarbamylase deficiency (OTCD) is a rare, X linked disorder that can manifest in late adulthood in heterozygous females as severe hyperammonaemia following environmental stressors. We present a case of hyperammonaemic encephalopathy that was triggered by glucocorticoid administration in an adult woman with heterozygous OTCD with clinical response to haemodialysis, ammonia scavengers and a high-calorie, low-protein diet.
Immune checkpoint inhibitor lichenoid eruption due to pembrolizumab

BMJ Case Reports | June 20, 2023 | Volume: 16 | Issue: 6 | Pages: e254692

10.1136/bcr-2023-254692 | PMID 37339826

Pembrolizumab is an immune checkpoint inhibitor used in many cancer types, including genitourinary cancers. Although immunotherapies have dramatically changed the landscape of cancer treatment by providing an alternative to traditional chemotherapy, they have been associated with significant immune-related adverse events (IRAEs) with wide-ranging clinical manifestations. We present the case of an elderly woman on pembrolizumab for metastatic bladder cancer who developed cutaneous IRAE with lichenoid eruptions that responded to high-dose intravenous glucocorticoids.
Risk of Postoperative Thromboembolism in Men Undergoing Urological Prosthetic Surgery: An Assessment of 21,413 Men

Journal of Urology | June 10, 2022 | Volume: 208 | Issue: 4 | Pages: 878-885

10.1097/ju.0000000000002801 | PMID 35686836